Clinical Trial Update: Imaging and Biomarkers of Hypoxia in Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating imaging and biomarkers of hypoxia in solid tumors; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Snippet

Sponsor: Stanford University | Conditions: Neoplasms | Phase 1 | Status: TERMINATED